As previously reported, CT26 tumors have a lower mutational load and exhibit characteristics approximating those of MSS/pMMR colorectal cancer, showing poor response to anti-PD1 antibody monotherapy [36,37,38]. Here, PDCD1 is linked to colorectal cancer.